Asia · Markets & Finance · CNBC-TV18

Glenmark expects innovative drugs to drive higher revenue share: CMD Glenn Saldanha

Published by CNBC-TV18 · India 2 h ago

Glenmark Pharmaceuticals expects innovative drugs to contribute a higher share of revenue as it shifts focus beyond generics, CMD Glenn Saldanha said.

Read the full article on CNBC-TV18 Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Tech in Asia

Glenmark expects innovative drugs to drive higher revenue share: CMD Glenn Saldanha

Share

Also worth reading

Foxconn revenue jumps 47% on strong AI server demand

Indian wrestlers turn Japan success into LA mission

Raymond Realty gains 6%, snaps 4-day losing run on strong Q2 biz update

Malaysian palm oil stockpiles balloon to record on output surge

Singapore 9-month investment banking fees reach 5-year high of US$693.8 million

Hong Kong lawmakers say 5-year tax incentive too short to entice major innovative firms